Skip to main content
. 2017 Jun 8;53(3):387–396. doi: 10.1007/s00535-017-1356-8

Table 2.

Concomitant medications and LCAP treatment status

Item No. of patients %
Concomitant medications
 During LCAP
  5-ASA 286 95.3
  Thiopurine 101 33.7
  Corticosteroid 183 61.0
 Beginning of the observation period
  Corticosteroid 163 54.3
 During the observation period
  5-ASA 280 93.3
  Thiopurine 130 43.3
LCAP treatment status
 Number of sessions
  5–7 46 15.8
  8–9 17 5.8
  10 228 78.4
 Frequency of LCAP
  Weekly 88 30.2
  Intensive 203 69.8

5-ASA 5-aminosalicylic acid, LCAP leukocytapheresis